Best Agrolife reported a weak Q3 FY26 with revenue of 202.9 crore, down 26% YoY, due to excessive rainfall and low pest pressure disrupting crop cycles.
Financial stats pending filing verification
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Outstanding warrants with exercise price of ~42 rupees (post-split) are far above current market price of ~19 rupees, potentially leading to non-exercise and equity dilution or failed capital raise.
high · analyst_questionPotential El Niño conditions could disrupt crop cycles and reduce demand for agrochemicals, impacting revenue recovery plans.
medium · analyst_questionInterest costs of 50-55 crore annually exceed net profits, raising sustainability concerns if profitability does not improve.
high · analyst_questionNon-patent portfolio declined 48% in 9M FY26, indicating potential market share loss as company pivots to patented products.
medium · data_observation